Literature DB >> 308001

[Porphyria cutanea tarda: possible treatment and its results (author's transl)].

G Goerz, T Krieg.   

Abstract

In 4 of 12 patients with porphyria cutanea tarda (PCT) treatment with p-aminobenzoic acid (PABA) achieved normal porphyrin excretion and disappearance of the skin changes. But this result is far worse than that obtained with the venesection method of Ippen. PABA treatment should, therefore, be discontinued.--Among 56 patients (37 males, 19 females) given chloroquine treatment (twice 125 mg per week), normal porphyrin excretion and disappearance of the skin changes occurred in 32 after an average duration of treatment of 8 months, while in 21 (15 males and 6 females) an improvement set in after an average treatment duration of only 5 months so far. The treatment failed in three patients, but one of them lapsed his treatment and one died of an intercurrent disease, so that only one can be reckoned a true failure of chloroquine treatment.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 308001     DOI: 10.1055/s-0028-1129257

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  3 in total

1.  [Death following administration of 1,250 mg chloroquine in porphyria cutanea tarda].

Authors:  G Drasch; W Eisenmenger
Journal:  Z Rechtsmed       Date:  1986

2.  [Hereditary and non-hereditary form of chronic hepatic porphyria: different behaviour of uroporphyrinogen decarboxylase in liver and erythrocytes (author's transl)].

Authors:  M Doss; R von Tiepermann; D Look; H Henning; J Nikolowski; F Ryckmanns; O Braun-Falco
Journal:  Klin Wochenschr       Date:  1980-12-15

3.  [Influence of chloroquine on the hexachlorobenzene-induced porphyria. Investigations in the skin, liver, and urine (author's transl)].

Authors:  W Vizethum; K Bolsen; K Simon; K Weber; G Goerz
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.